At Bigtec Labs, we will continue to build and push the boundaries of medical diagnosis
Vyas Sivanand, Indian Express, July 13, 2019
http://epaper.newindianexpress.com/c/41357488
Founded in 2000, Bengaluru- based Bigtec Labs was formed to address the need for 'gold standard' diagnosis at 'near care' locations so that care givers are able to provide precise rather than presumptive diagnosis...
Read morePublished Research Article: Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
Author: DJ Lee et al., 2019, July 02, 2019
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218890
Truenat is a novel molecular assay that rapidly detects tuberculosis (TB) and rifampicin-resistance. Due to the portability of its battery-powered testing platform, it may be valuable in peripheral healthcare settings in India...Read more
Molbio Diagnostics Lab On A Chip-MDx Platform, The Global First
Sumit Mitra, June 21, 2019
https://www.medicaltechoutlook.com/magazines/July2019/InVitroDiagnostics/#page=37
In Vitro Diagnostic Special MedTech Outlook, July 01, 2019
Read moreEureka now testing for cancer, infectious diseases
Staff Reporter, Guyana Chronicle, May 11, 2019
https://guyanachronicle.com/2019/05/11/eureka-now-testing-for-cancer-infectious-diseases
EUREKA Lab, in celebrating its 24th Anniversary in the business, launched a new Polymerase Chain Reaction (PCR) system which will test for Cervical Cancer and infectious diseases....
Read moreIndian-made diagnostic test for TB being validated
Staff Reporter, The Hindu, March 23, 2019
https://www.thehindu.com/news/cities/chennai/indian-made-diagnostic-test-for-tb-being-validated/article26614321.ece
WHO chief scientist calls for higher investment on TB control:The World Health Organisation (WHO) is working with the Indian Council of Medical Research (ICMR) on validating an Indian-made diagnostic test for tuberculosis...
Read moreTrueNat: India made TB diagnostic test being validated by WHO
The Policy Times Bureau, March 23, 2019
http://thepolicytimes.com/trunat-india-made-tb-diagnostic-test-being-validated-by-who/
“We have the Indian-made diagnostic test- TruNat - that is in the process of getting validated. It will be the first point of care molecular TB diagnostic test that can be taken into a primary health centre and used because it is battery-operated. It is much more user-friendly that GeneXpert.” Dr Soumya Swaminathan.
Read moreDoctors focus on infection control, role of surgery to treat tuberculosis.
Ritika Gupta, January 06, 2019
https://timesofindia.indiatimes.com/city/nagpur/docs-focus-on-infection-control-role-of-surgery-to-treat-tb/articleshow/67398159.cms?utm_source=contentofinterest&&&utm_medium=text&utm_campaign=cppst
Experts focused on topics like infection control in interventional pulmonology, role of surgery in tuberculosis treatment and lung cancer on the second day of the 73 rd National Conference of Tuberculosis and Chest Diseases on Saturday...
Read moreThe Stop TB Partnership welcomes India's Andhra Pradesh State innovative private-public approach to ending TB
Sreenivas Nair, Regional Advisor, Country and Community Support For Impact Team, The Stop TB Partnership,, December 15, 2018
http://www.stoptb.org/news/stories/2018/ns18_080.asp
Earlier this year Andhra Pradesh, home to 50 million people, was prestigiously recognized by the Indian Ministry of Health as the leading state in the battle against TB...
Read moreQuantuMDx and Molbio announce Memorandum of Understanding (MoU) at Future Tech Festival
December 12, 2018
https://quantumdx.com/news/quantumdx-molbio-mou
QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working...
Read moreTo Tackle the Tuberculosis Crisis, Diagnostics Must Be Brought Closer to Patients
Biraj Swain,, November 30, 2018
https://thewire.in/health/to-tackle-the-tuberculosis-crisis-diagnostics-must-be-brought-closer-to-patients
Tuberculosis is the world's top infectious killer. In 2017, it killed 1.6 million people. The same year, ten million more were infected. India contributes 27% of the global TB burden...
Read more
